中基健康拟购买新业能化100%股权 形成化工与食品加工双主业格局

Core Viewpoint - The acquisition of Xin Ye Energy Chemical by Zhong Ji Health aims to diversify its business and enhance its competitive position in both the chemical and food processing industries, while also aligning with national policies for state-owned enterprise reform [1][3]. Group 1: Acquisition Details - Zhong Ji Health plans to issue shares to acquire 100% of Xin Ye Energy Chemical, which will become a wholly-owned subsidiary [1]. - The transaction is expected to result in Xin Ye Group becoming the controlling shareholder of Zhong Ji Health, with the Xinjiang State-owned Assets Supervision and Administration Commission as the actual controller [1]. - The acquisition is classified as a related party transaction due to Xin Ye Group's association with the listed company [1]. Group 2: Xin Ye Energy Chemical Overview - Xin Ye Energy Chemical is the longest modern coal chemical industry chain enterprise in Xinjiang, utilizing abundant coal resources to produce natural gas, methanol, and other chemical products [2]. - The company has established a circular economy integrated industrial chain, enhancing its bargaining power within the industry [2]. - Xin Ye Energy Chemical reported net profits of 509 million, 797 million, 535 million, and 284 million yuan for the years 2021, 2022, 2023, and the first nine months of 2024, respectively [2]. Group 3: Impact on Zhong Ji Health - The acquisition will allow Zhong Ji Health to expand its business scope, creating a dual focus on chemicals and food processing, thereby enhancing overall competitiveness and market influence [2]. - The transaction is expected to improve the company's asset and business scale, optimize its industrial structure, and enhance its operational sustainability and risk resistance [2]. - Following the acquisition, Zhong Ji Health plans to leverage its organizational and governance experience to improve production efficiency at Xin Ye Energy Chemical [3]. Group 4: Financial Performance and Strategy - Zhong Ji Health anticipates a net loss of 150 million to 250 million yuan for 2024, a significant decline compared to a profit of 108 million yuan in the previous year, primarily due to reduced sales and prices of its main products [3][4]. - The company is increasing efforts to recover debts, with non-recurring gains expected to impact net profit by approximately 77.4 million yuan [4]. - Zhong Ji Health is also working on optimizing its product structure and enhancing domestic market strategies to improve sales channels [4].